Rapid augmentation in the prevalence of multidrug-resistant (MDR) Staphylococcus aureus is a worldwide threat. Advising newer antibiotics may fail to reduce the chances of the emergence of newer drug-resistant Staphylococcus aureus. Very little shreds of evidence can be found to treat clinical MDR Staphylococcus aureus with biogenic silver nanoparticles (AgNPs) in West Bengal. To prepare […]
